GW873140 In Combination With Kaletra In HIV Infected Subjects

Mise à jour : Il y a 4 ans
Référence : NCT00102778

Femme et Homme

Extrait

This study is a 96-week study designed to evaluate the safety and efficacy of GW873140 in combination with Kaletra in HIV infected, untreated subjects.


Critère d'inclusion

  • Infection, Human Immunodeficiency Virus I ,HIV infection


Liens